5-year survivors | Non-survivors | p Value | ||
Age | <65 | 15 | 7 | 0.028 |
≥65 | 26 | 37 | ||
Gender | Male | 35 | 41 | 0.239 |
Female | 6 | 3 | ||
Smoking status | Current/former | 39 | 39 | 0.269 |
Never | 2 | 5 | ||
p-stage | I | 28 | 21 | 0.054 |
II-III | 13 | 23 | ||
pT status | pT1 | 22 | 16 | 0.108 |
pT2-3 | 19 | 28 | ||
pN status | pN0 | 35 | 27 | 0.011 |
pN1-2 | 6 | 17 | ||
Tumor location | Central | 19 | 21 | 0.898 |
Peripheral | 22 | 23 | ||
IP | IP+ | 3 | 10 | 0.043 |
IP− | 38 | 34 | ||
CEA | Normal | 30 | 31 | 0.781 |
High | 11 | 13 | ||
SCC | Normal | 28 | 16 | 0.003 |
High | 13 | 28 | ||
CYFRA 21-1 | Normal | 29 | 18 | 0.005 |
High | 12 | 26 | ||
SCC & CYFRA 21-1 | Both normal | 23 | 9 | 0.001 |
Others | 18 | 35 |